Skip to main content
Samuel W D Merriel

Samuel W D Merriel

Researcher

Sep 15, 2026

8:38
let's dive straight in and i guess a good place to start would be to have a recap on the nsc's prostate screening decision could you give us a quick refresher on that
8:49
absolutely and i thought you summarized the timeline of the last 12 months or so perfectly but just for a bit of context for your listeners so The National Screening Committee is an independent body appointed to advise government on screening programs, and that includes cancer.
9:03
They have looked at the issue of PSA-based prostate cancer screening multiple times over the last 10 to 15 years.
9:09
And each time in the past, they've come to the conclusion, looking at all the available evidence from the big trials and the economic analyses, that the potential benefits of regular PSA-based prostate cancer screening don't clearly outweigh the potential harms.
9:23
and they haven't recommended a national screening program for prostate cancer for the whole population at any point they've looked at it.
9:28
The change that's happened is that last year they looked at high-risk groups, and the one group that they have recommended targeted screening for now is men who carry the BRCA2 variant.
9:41
So BRCA2 is probably pretty familiar to your listeners.
14:03
Can you try and reconcile this for us a bit?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.